1 / 45

Local and Global Public Health Links: Preparation for an Influenza Pandemic

Local and Global Public Health Links: Preparation for an Influenza Pandemic. Nicole J. Cohen, MD, MSc Chicago Department of Public Health The University of Chicago’s Summer Institute for Educators June 29, 2006. Influenza Virus. Three types of influenza virus: A, B, C

tave
Download Presentation

Local and Global Public Health Links: Preparation for an Influenza Pandemic

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Local and Global Public Health Links: Preparation for an Influenza Pandemic Nicole J. Cohen, MD, MSc Chicago Department of Public Health The University of Chicago’s Summer Institute for Educators June 29, 2006

  2. Influenza Virus • Three types of influenza virus: A, B, C • Only influenza A and B viruses cause significant disease and epidemics in humans

  3. Influenza A Viruses • Classified into subtypes based on two surface proteins, hemagglutinin (HA) and neuraminidase (NA) • 16 HAs and 9 NAs in total • Currently in humans: • H1N1 • H3N2

  4. Influenza A Susceptible Hosts

  5. Influenza B Viruses • No subtypes • Infect humans almost exclusively

  6. Avian Influenza • Infection of bird with influenza A virus • Different strains from the ones that cause human infections annually • Occurs naturally • High vs low pathogenicity viruses • Highly contagious among bird populations • Usually spread from wild birds to domestic poultry • May be carried by birds without causing disease • May cause severe illness and/or death among birds • Rarely infects humans

  7. Symptoms of Avian Influenza in Humans • Wide range of symptoms depending on type of virus • Typical flu symptoms (fever, cough, sore throat, muscle aches) • Conjunctivitis (eye infection) • Viral pneumonia • Severe respiratory illness • May be life threatening

  8. H5N1 Influenza Virus • 1996 First identified in a goose in China • 1997 First human cases in Hong Kong • 18 confirmed cases, 6 deaths • 150 million chickens slaughtered to control outbreak • 2/2003 Two cases in a Hong Kong family who traveled to mainland China

  9. Azerbaijan Cambodia China Djibouti Egypt Indonesia Iraq Thailand Turkey Viet Nam Current Situation Human Cases -- June 20, 2006 228 Cases 130 deaths Death rate approximately 50%

  10. How avian influenza infects people • Virus present in respiratory secretions and feces of infected birds • Human infection has resulted from • Close contact with infected birds • Contact with or consumption of raw poultry products • Contact with contaminated surfaces (feces) • Generally has not spread from person to person • Has been suggested in several small family clusters after extremely close contact with sick person • Has not spread beyond one person • Has not spread to health care workers

  11. How human influenza spreads • Respiratory droplets • Coughing, sneezing • Spreads through close contact (less than 3 feet) • Prevent by “covering cough”, wearing masks in medical situations • Hand contamination then touching eyes, nose, or mouth • Direct contact e.g. shaking hands with infected person • Contact with objects contaminated by influenza viruses (e.g. doorknobs, phones) • Prevent by hand hygiene, gloves in medical situations

  12. H5N1: Is there a vaccine? • A vaccine against H5N1 is under development • Not commercially available • Annual influenza vaccine does not protect against H5N1

  13. H5N1: Is treatment available? • Most H5N1 viruses are resistant to older class of antivirals (amantadine and rimantadine) • May be treated with newer antivirals Tamiflu® or Relenza® • Effectiveness is not known • Some resistance to Tamiflu® has been identified

  14. Advice for Travelers • CDC has not recommended that the general public avoid travel to any of the countries affected by avian influenza • Receive routine flu vaccine (if available) prior to departure • If traveling to any country with a known outbreak of H5N1 influenza • Avoid poultry farms • Avoid contact with animals in live food markets • Avoid contact with any surfaces that appear to be contaminated with feces from poultry or other animals

  15. Advice for Travelers • Practice careful hand hygiene, especially after handling raw poultry • It is safe to eat poultry or eggs that have been properly handled and cooked • Monitor your health for 10 days after returning • Seek medical attention if symptoms of fever or respiratory illness develop

  16. Pandemic Influenza • Worldwide outbreak of a novel (new) influenza virus • Occurs infrequently and at irregular intervals • Unpredictable • Potential for substantial impact • Morbidity (illness) and mortality (death) • Social disruption • Economic costs

  17. 20th Century Influenza Pandemics • 1918-1919: “Spanish Flu” (H1N1) • > 500,000 US deaths • > 20 million deaths worldwide • 1957-1958: “Asian Flu” (H2N2) • 70,000 US deaths. • 1968-1969: “Hong Kong Flu” (H3N2) • 34,000 US deaths

  18. Influenza Pandemic 1918

  19. How does a pandemic happen? • 4 factors must be present: • Novel virus • Virus capable of causing disease in humans • Susceptible population • Virus that is transmissible from person to person • Current avian influenza outbreak is not a pandemic

  20. Where do new influenza strains come from? • Mixing of human and animal influenza strains • Adaptation of an animal strain to allow person to person spread

  21. WHO Pandemic Phases

  22. Issues of Concern • Potential rapid worldwide spread due to global trade and international travel • Medical resources may be insufficient • Medical personnel at high risk of infection • Pandemic would likely be prolonged • Community infrastructure disruption • Major economic impact

  23. Estimated Impact of “Medium-Level” Pandemic, US • As much as 35% of population could be affected • ~ 47 million people • As many as 734,000 hospitalizations • As many as 207,000 deaths • Economic impact could range between $71.3 and $166.5 billion

  24. On the bright side… • Pandemic influenza planning is occurring at the local, state, national and international levels • Surveillance for new influenza strains in birds and humans is ongoing to allow for early detection • Experience with SARS has led to increased awareness and preparedness to deal with global infectious disease emergencies • Medical care and isolation capabilities are more sophisticated than during 1918

  25. Global Public Health Surveillance • International Health Regulations revised 2005 • Defines Public Health Emergency of International Concern (PHEIC) • Contains a decision instrument to help countries determine whether reporting to WHO is necessary • Includes a list of diseases to be reported immediately, even if single case • Encourages countries to consult WHO for events that may be of public health relevance

  26. Pandemic Influenza Planning • Goals • Limit total burden of disease (illness and death) • Decrease social disruption • Decrease economic loss • Engage all levels of health care system, public health, and emergency response • Include public and private sectors • Key similarities (and differences) between pandemic response and other health emergencies • Planning, resources, and implementation

  27. Local Planning an Influenza Pandemic • Surveillance recommendations • Laboratory recommendations • Antiviral plan • Vaccine distribution plan • Containment including isolation and quarantine issues • Surge capacity, mortuary issues, and mass care • Communications • Public information

  28. Vaccine and Antiviral Medications • Vaccine • Will probably not be available in early stages of a pandemic • Even when vaccine does become available, supplies will be limited • Prioritization will have to occur • Antiviral medications • Stockpiled supplies are limited but increasing • Resistance may be a problem • Prioritization will have to occur

  29. Controlling a Pandemic • Early identification and isolation of ill people will be critical • Close monitoring and possible quarantine of exposed contacts • Basic infection control measures • “Social Distancing” • Public transportation • Large gatherings/special events • Schools

  30. Preventing Spread of Influenza • Preventing illness: • Wash your hands • Stay away from people who are sick • Get your flu vaccine! • If symptomatic with a respiratory illness: • “Cover Your Cough” • Wash your hands! • Don’t visit friends or family in hospital or a long term care facility • If diagnosed with influenza: • Don’t go to work or attend school while symptomatic

  31. Corporate (Workplace) Preparedness • Encourage respiratory and hand hygiene in the workplace • Ensure appropriate hygiene supplies and facilities are available • Discourage employees diagnosed with influenza from working while symptomatic • Plan for functioning with high levels of absenteeism • Mechanisms for employees to work from home, if possible

  32. Preparedness in Schools • Hygiene messages/posters • Disease surveillance • Systematic exclusion of sick students and staff • Consider the possibility of school closures • Who makes this decision? • Mandatory closures vs self-shielding behaviors • Continuity of education

  33. Personal/Family Emergency Preparedness • Prepare a disaster supply kit for 3 days (general emergencies) • Create a Family Emergency Plan • Know where to access accurate information

  34. Personal and Corporate Antiviral Stockpiles – A Bad Idea!!! • Depletion of resources from the public sector • Inadequate supplies for treatment and prophylaxis during seasonal influenza outbreaks • Potential for misuse (wasting) during non-influenza respiratory infections • Potential for development of resistance • Incomplete courses, incorrect dosing, sharing • Cost • Inequitable distribution of drug • Shelf life/expiration

  35. For more information • http://www.cdc.gov/flu/avian/ • http://www.who.int • http://pandemicflu.gov/

More Related